Scotiabank lowered the firm’s price target on AvePoint (AVPT) to $17 from $22 and keeps an Outperform rating on the shares. The firm notes there were pluses and minuses to the quarter, with ARR only in line with consensus and no guidance raise paired with ARR growth and impressive operating margins, the analyst tells investors. With shares down 20% over the past three months, the firm believes the shares look “attractive.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVPT:
- AvePoint price target lowered to $18 from $22 at Evercore ISI
- AvePoint price target lowered to $18 from $22.50 at Cantor Fitzgerald
- AvePoint price target lowered to $16 from $17 at Baird
- AvePoint’s Strong Performance and Strategic AI Positioning Earns Buy Rating
- AvePoint Reports Strong Q3 2025 Financial Growth
